These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27769706)

  • 1. Risk factors for high death and loss-to-follow-up rates among patients with multidrug-resistant tuberculosis at a programmatic management unit.
    Javaid A; Shaheen Z; Shafqat M; Khan AH; Ahmad N
    Am J Infect Control; 2017 Feb; 45(2):190-193. PubMed ID: 27769706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan.
    Khan I; Ahmad N; Khan S; Muhammad S; Ahmad Khan S; Ahmad I; Khan A; Gulalai ; Atif M
    J Infect Public Health; 2019; 12(6):809-815. PubMed ID: 31056438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with mortality to drug-resistant tuberculosis and their programmatic management in treatment centres of Punjab, Pakistan.
    Kanwal S; Akhtar AM; Ahmed A
    J Pak Med Assoc; 2017 Jun; 67(6):858-862. PubMed ID: 28585582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with loss to follow-up and death in cases of drug-resistant tuberculosis (DR-TB) treated at a reference center in Rio de Janeiro, Brazil.
    Viana PVS; Redner P; Ramos JP
    Cad Saude Publica; 2018 May; 34(5):e00048217. PubMed ID: 29768580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance.
    Ahmad N; Javaid A; Basit A; Afridi AK; Khan MA; Ahmad I; Sulaiman SA; Khan AH
    Int J Tuberc Lung Dis; 2015 Sep; 19(9):1109-14, i-ii. PubMed ID: 26260834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and treatment outcomes of patients with multi-drug resistant tuberculosis at a tertiary care hospital in Peshawar, Pakistan.
    Khan MA; Mehreen S; Basit A; Khan RA; Jan F; Ullah I; Ihtesham M; Khan A; Ullah U; Javaid A
    Saudi Med J; 2015 Dec; 36(12):1463-71. PubMed ID: 26620989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study.
    Leimane V; Riekstina V; Holtz TH; Zarovska E; Skripconoka V; Thorpe LE; Laserson KF; Wells CD
    Lancet; 2005 Jan 22-28; 365(9456):318-26. PubMed ID: 15664227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis.
    Chan ED; Laurel V; Strand MJ; Chan JF; Huynh ML; Goble M; Iseman MD
    Am J Respir Crit Care Med; 2004 May; 169(10):1103-9. PubMed ID: 14742301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.
    Chiang CY; Enarson DA; Yu MC; Bai KJ; Huang RM; Hsu CJ; Suo J; Lin TP
    Eur Respir J; 2006 Nov; 28(5):980-5. PubMed ID: 16837502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobectomy or pneumonectomy for multidrug-resistant pulmonary tuberculosis can be performed with acceptable morbidity and mortality: a seven-year review of a single institution's experience.
    Mohsen T; Zeid AA; Haj-Yahia S
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):194-8. PubMed ID: 17599508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term outcome of multidrug-resistant TB patients in Fukujuji Hospital in Japan.
    Yoshiyama T; Morimoto K; Okumura M; Sasaki Y; Ogata H; Shiraishi Y; Kudou S
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):589-90. PubMed ID: 24902580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
    Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It.
    Shringarpure KS; Isaakidis P; Sagili KD; Baxi RK
    PLoS One; 2015; 10(7):e0132543. PubMed ID: 26167891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
    Kempker RR; Kipiani M; Mirtskhulava V; Tukvadze N; Magee MJ; Blumberg HM
    Emerg Infect Dis; 2015 Jun; 21(6):992-1001. PubMed ID: 25993036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight variation over time and its relevance among multidrug-resistant tuberculosis patients.
    Chung-Delgado K; Revilla-Montag A; Guillén-Bravo S; Bernabe-Ortiz A
    Int J Infect Dis; 2014 Jun; 23():20-4. PubMed ID: 24657270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
    Sagwa EL; Ruswa N; Mavhunga F; Rennie T; Leufkens HG; Mantel-Teeuwisse AK
    BMC Pharmacol Toxicol; 2015 Dec; 16():36. PubMed ID: 26654443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa.
    Moyo S; Cox HS; Hughes J; Daniels J; Synman L; De Azevedo V; Shroufi A; Cox V; van Cutsem G
    PLoS One; 2015; 10(3):e0118919. PubMed ID: 25785451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for unfavorable outcome of pulmonary tuberculosis in adults in Taipei, Taiwan.
    Yen YF; Yen MY; Shih HC; Deng CY
    Trans R Soc Trop Med Hyg; 2012 May; 106(5):303-8. PubMed ID: 22387265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands.
    Geerligs WA; Van Altena R; De Lange WCM ; Van Soolingen D; Van Der Werf TS
    Int J Tuberc Lung Dis; 2000 Aug; 4(8):758-64. PubMed ID: 10949328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.